3 ·Filed Oct 1, 2026
Form 3 — initial insider ownership statement
Actionable Insight • Neutral
No trading signal from this filing. Monitor for future insider transactions or changes in ownership that could signal conviction.
Latest settled — T+5d
UNCY ▼ -2.61% at T+5d
NEUTRAL call -2.61% · α vs SPY -3.77% · entry $4.22 → $4.11
Latest observation: T+15 +3.39% FF3 residual α
T+1d
-0.71%
call -0.71% · α -1.39%
$4.19
settled 25d ago
T+5d
-2.61%
call -2.61% · α -3.77%
$4.11
settled 19d ago
T+20d
Pending
in 2d
T+60d
Pending
in 2mo
Price Chart
Loading chart...
Executive Summary
Meredith Manning filed a Form 3 initial statement of beneficial ownership with Unicycive Therapeutics, reporting no securities owned. This is a routine administrative filing by a new insider with no holdings disclosed.
Key Facts
- Meredith Manning filed Form 3 as a reporting owner of Unicycive Therapeutics.
- The filing reports zero beneficial ownership of the company's securities.
- Filed on 2026-10-01, with a period of report of the same date.
Financial Impact
No financial impact — insider holds zero shares.
Risk Factors
- No material risks identified from this filing.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001213900-26-105816 |
| Document: 0001213900-26-105816-index.html | 0001213900-26-105816 |
| Document: 0001213900-26-105816.txt | 0001213900-26-105816 |
11 reports for UNCY
100% Hit rate @ T+60 Went positive at some point 4 of 4 best @ T+60▲ +38.19%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 25d ago | 3 | $4.22 | awaiting T+60 | — | $3.58 (−15.17%) |
Sep 29, 2026 27d ago | 8-K | $4.55 | awaiting T+60 | — | $3.58 (−21.32%) |
Aug 12, 2026 10w ago | 8-K | $5.39 | awaiting T+60 | — | $3.58 (−33.58%) |
Jul 2, 2026 16w ago | 8-K | $5.73 $4.81 | ▼ −16.06% | ▼ −19.06% | $3.58 (−37.52%) |
Jun 22, 2026 18w ago | DEFA14A | $7.87 $4.71 | ▼ −40.15% | ▼ −41.90% | $3.58 (−54.51%) |
Jun 16, 2026 19w ago | EFFECT | $7.17 $5.31 | ▲ +25.94% | ▲ +26.94% | $3.58 (+50.07%) |
Jun 5, 2026 20w ago | S-3 | $6.66 $5.05 | ▲ +24.17% | ▲ +27.23% | $3.58 (+46.25%) |
May 12, 2026 23w ago | 8-K | $8.17 $5.05 | ▼ −38.19% | ▼ −42.57% | $3.58 (−56.18%) |
May 12, 2026 23w ago | Press Release | $8.17 $5.05 | ▲ +38.19% | ▲ +42.57% | $3.58 (+56.18%) |
Apr 6, 2026 29w ago | 8-K | $6.62 $5.28 | ▼ −20.24% | ▼ −33.71% | $3.58 (−45.92%) |
Showing 10 of 11
US Market Status
Market Closed — Opens in 2h 28m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers